ArticleJournal of experimental & clinical cancer research : CR2022

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.

Yuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.